REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 142 filers reported holding REVOLUTION MEDICINES INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $108,395 | -5.9% | 3,916 | -9.1% | 0.07% | -2.9% |
Q2 2023 | $115,186 | +27.6% | 4,306 | +3.3% | 0.07% | +36.0% |
Q1 2023 | $90,301 | -34.3% | 4,169 | -27.8% | 0.05% | -30.6% |
Q4 2022 | $137,465 | +11.8% | 5,771 | -7.1% | 0.07% | +46.9% |
Q3 2022 | $123,000 | +2.5% | 6,214 | +0.7% | 0.05% | +11.4% |
Q2 2022 | $120,000 | -26.4% | 6,169 | -3.2% | 0.04% | -39.7% |
Q1 2022 | $163,000 | -4.1% | 6,375 | -5.5% | 0.07% | +14.1% |
Q4 2021 | $170,000 | +0.6% | 6,746 | +9.7% | 0.06% | -13.5% |
Q3 2021 | $169,000 | -17.6% | 6,150 | -5.0% | 0.07% | -11.9% |
Q2 2021 | $205,000 | -35.5% | 6,471 | -6.6% | 0.08% | -37.3% |
Q1 2021 | $318,000 | +18.2% | 6,925 | +1.8% | 0.13% | +19.6% |
Q4 2020 | $269,000 | -9.4% | 6,805 | -20.3% | 0.11% | -28.2% |
Q3 2020 | $297,000 | -2.9% | 8,538 | -12.0% | 0.16% | +7.6% |
Q2 2020 | $306,000 | – | 9,701 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |